AADI Company Profile and Key Details
Aadi Bioscience, Inc.
AADI Stock Price Chart
Stock Price Today
Aadi Bioscience, Inc. (AADI) stock declined over -0.37%, trading at $2.73 on NASDAQ, down from the previous close of $2.74. The stock opened at $2.70, fluctuating between $2.66 and $2.80 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Company Information
| Employees | 53 |
| Beta | 0.37 |
| Sales or Revenue | $24.35M |
| 5Y Sales Change% | -0.898% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Aadi Bioscience, Inc. (NASDAQ: AADI) stock price is $2.73 in the last trading session. During the trading session, AADI stock reached the peak price of $2.80 while $2.66 was the lowest point it dropped to. The percentage change in AADI stock occurred in the recent session was -0.37% while the dollar amount for the price change in AADI stock was -$0.01.
The NASDAQ listed AADI is part of Biotechnology industry that operates in the broader Healthcare sector. Aadi Bioscience, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Raymond G. Steitz
Senior Vice President of HR & Chief HR Officer
Dr. Loretta M. Itri F.A.C.P., M.D.
Chief Medical Officer
Mr. Scott M. Giacobello CPA
Interim Chief Executive Officer, Pres, Chief Financial Officer & Treasurer
Ms. Marcy Graham
SVice President of Investor Relations & Corporation Communications
Mr. Bryan Ball
Chief Quality Officer & Senior Vice President of Manufacturing Operations
Mr. Brendan P. Delaney M.B.A.
Pres, Chief Executive Officer & Director
Dr. Neil P. Desai Ph.D.
Founder, Sec. & Executive Chairman
Mr. Stephen M. Rodin J.D.
Senior Vice President of Legal & Gen. Counsel
AADI's closing price is 125.62% higher than its 52-week low of $1.21 where as its distance from 52-week high of $3.81 is -28.38%.
Number of AADI employees currently stands at 53.
Official Website of AADI is: https://aadibio.com
AADI could be contacted at phone 424 473 8055 and can also be accessed through its website. AADI operates from 17383 Sunset Boulevard, Pacific Palisades, CA 90272, United States.
AADI stock volume for the day was 88.57K shares. The average number of AADI shares traded daily for last 3 months was 379.55K.
The market value of AADI currently stands at $67.42M with its latest stock price at $2.73 and 24.7M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com